Trump Rescinds Biden's Drug Cost Reduction Orders

President Trump has rescinded several Biden-era executive orders aimed at reducing prescription drug costs for Medicare and Medicaid recipients, including efforts under the Inflation Reduction Act. These rollbacks affect initiatives like capping certain generic drugs at $2 and allowing federal negotiation of drug prices, though the $2,000 annual out-of-pocket cap on prescription drugs remains unaffected. While some experts suggest these changes may not significantly impact out-of-pocket expenses for many Americans, local pharmacies express concern about the economic effects on their businesses. The rollback also negates policies that sought to enhance access to innovative drug therapies and reduce costs through new healthcare payment models. Trump's actions indicate a shift away from Biden's healthcare agenda, labeling his policies as 'unpopular' and 'radical'.